Simplex Trading’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.28M Sell
325,509
-239,737
-42% -$5.16M 0.01% 794
2026
Q1
$6.48M Sell
565,246
-73,990
-12% -$1.04M ﹤0.01% 938
2025
Q4
$9.19M Buy
639,236
+218,403
+52% +$3.78M 0.01% 902
2025
Q3
$7.97M Buy
420,833
+210,057
+100% +$3.46M ﹤0.01% 1116
2025
Q2
$4.52M Buy
+210,776
New +$3.13M ﹤0.01% 1433
2024
Q4
– Sell
-14,384
Closed -$232K – 9329
2024
Q3
$305K Sell
14,384
-73,736
-84% -$1.33M ﹤0.01% 4111
2024
Q2
$1.39M Buy
88,120
+40,207
+84% +$739K ﹤0.01% 2565
2024
Q1
$712K Sell
47,913
-16,078
-25% -$220K ﹤0.01% 3473
2023
Q4
$585K Buy
+63,991
New +$442K ﹤0.01% 3526
2023
Q1
– Sell
-13,090
Closed -$53.4K – 9832
2022
Q4
$32K Buy
13,090
+9,053
+224% +$28.3K ﹤0.01% 6385
2022
Q3
$20K Sell
4,037
-18,126
-82% -$106K ﹤0.01% 7531
2022
Q2
$94K Buy
+22,163
New +$141K ﹤0.01% 5643
2021
Q4
– Sell
-31,026
Closed -$390K – 11161
2021
Q3
$659K Hold
31,026
– – ﹤0.01% 3687
2021
Q2
$667K Buy
31,026
+30,947
+39,173% +$741K ﹤0.01% 3731
2021
Q1
$2K Buy
+79
New +$2.47K ﹤0.01% 8475

Other funds holding OSCR

Simplex Trading's OSCR Position: Q2 2026 in Review

Simplex Trading reduced its Oscar Health (OSCR) stake by 42% in Q2 2026, selling an estimated $5.16M and leaving 325,509 shares worth $9.28M. The position accounts for 0.01% of the portfolio, ranked #794.

Simplex Trading first reported a position in OSCR in Q1 2021 and has held it in 15 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Simplex Trading held 325,509 shares of Oscar Health worth $9.28M as of Q2 2026.
  • Simplex Trading sold 239,737 Oscar Health shares in Q2 2026, an estimated $5.16M.
  • Oscar Health made up 0.01% of Simplex Trading's portfolio in Q2 2026, its #794 holding.
  • Simplex Trading first reported a position in Oscar Health in Q1 2021 and has held it in 15 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.